by Kimberly Waller | Jul 28, 2026
David Kuter, MD, DPhil, Director of Clinical Hematology at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School, discusses cognitive impairment in patients with immune thrombocytopenia (ITP). ITP is an autoimmune bleeding disorder...
by Kimberly Waller | Jun 29, 2026
Vlado Perkovic, MD, Professor of Medicine and Provost at the University of New South Wales Sydney, discusses results from the VISIONARY clinical trial testing Voyxact (sibeprenlimab) in patients with IgA nephropathy (IgAN). IgAN is due to the accumulation of...
by Kimberly Waller | Jun 12, 2026
Kerrie-Anne Ho, PhD, Patient Preference Lead at UCB, discusses preferences and perceptions of acute seizure medications. Data from interviews with people with seizures (PwS) and caregiver interviews were presented at the American Academy of Neurology (AAN) 2026...
by Kimberly Waller | May 26, 2026
Mauro Cives, MD, Associate Professor of Medical Oncology at the University of Bari, Italy, discusses the upcoming regulatory decision for LNTH-2501 to improve imaging of neuroendocrine tumors (NETs). NETs are rare tumors that usually develop in the...
by Kimberly Waller | May 21, 2026
A recent clinical study analysis of Oxbryta (voxelotor), globally withdrawn in 2024, was submitted to the FDA with the intent of getting voxelotor back on the market. Sickle cell disease (SCD) is a disorder in which red blood cells become “sickle”-shaped and can not...